FDA expedited access pathway enables staged approval opportunity for baroreflex activation therapy for heart failure with reduced ejection fraction: the BeAT-HF trial
23 May 2016 (08:30 - 18:00)
Organised by:
Abstract
Slides
About the speaker
The Ohio State University, Columbus (United States of America)
22 More presentations in this session
Access the full session
The Event
HEART FAILURE 2016
23 May 2016
08:30 CET
